1. Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M1‐acetylcholine receptor agonist: A randomized cross‐over trial. Issue 11 (8th May 2021) Authors: Bakker, Charlotte; Prins, Samantha; Liptrot, Jan; Hart, Ellen P.; Klaassen, Erica S.; Brown, Giles A.; Brown, Alastair; Congreve, Miles; Weir, Malcolm; Marshall, Fiona H.; Stevens, Jasper; Cross, David M.; Tasker, Tim; Nathan, Pradeep J.; Groeneveld, Geert Jan Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 11(2021) Page Start: 4439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First‐in‐man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M1‐receptor partial agonist for the treatment of dementias. Issue 7 (5th February 2021) Authors: Bakker, Charlotte; Tasker, Tim; Liptrot, Jan; Hart, Ellen P.; Klaassen, Erica S.; Prins, Samantha; van der Doef, Thalia F.; Brown, Giles A.; Brown, Alastair; Congreve, Miles; Weir, Malcolm; Marshall, Fiona H.; Cross, David M.; Groeneveld, Geert Jan; Nathan, Pradeep J. Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 7(2021) Page Start: 2945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗